October 2009 Archives

Oncolab is pleased to announce that AnyLabTestNow franchise locations now have the chance to become official draw sites for the AMAS test.  As locations are signed up their contact information will be placed into the Lab and Doctor maps found Here.  This is a great opportunity for AnyLabTestNow locations, Oncolab and most importantly for patients wanting to run the AMAS test.  Our goal is to make the process of taking the AMAS test as easy as possible and this is another step in that direction.

AnyLabTestNow

Margaret Rank, M.D.

"The AMAS test is a powerful diagnostic and prognostic tool when used properly. Measuring the levels of antibodies to Malignin, it can be used to diagnose sub-clinical cancer. That is, it can detect very small tumors before they become evident by usual diagnostic tests and physical exam. Small cancers can often be treated for cure with either conventional means or natural means. This is truly one of the weapons against cancer that is grossly underutilized.

Carol Ann Ryser, M.D.

"I believe that people with high risk in their family of cancer, or people over 45 or 50 should definitely take the test. People over 45 or 50 should be screened with the AMAS Test in the same way people receive routine mammographies and other kinds of tests including the PSA. I think the AMAS Test should be included."

In what they called a "watershed event," Canadian researchers reported that the genetic code of breast cancer evolves over time, a finding they said might lead to more targeted treatments. The researchers, using cutting edge gene sequencing technology... full story

SAN FRANCISCO -- Nearly three-quarters of breast cancer deaths occur among women who don't get regular screening mammograms, according to a large population-based study. Breast cancer mortality rates extrapolated from the findings were just 4.7% for... full story

By William Campbell Douglass II, M.D.

With the barrage of media hype surrounding breast cancer (and you're hearing more lately because this is National Breast Cancer Awareness Month), it's no wonder women often cite it as their primary health concern.

All this worry (and "awareness") has made breast cancer screening an enormous business. Women have been terrorized into having repeated mammograms, manual breast examinations, light exams, and anything else that can be dreamed up to get an early diagnosis.

For Full Article

By Dr. Adiel Tel-Oren 

While the medical community appears to be struggling ferociously with the specter of malignant disease, statistics show that in the last few decades cancer rates have been steadily increasing. Alarmingly, it is now estimated that one of three Americans will have had cancer during his or her lifetime. Should this trend continue, within several years it is likely that one of every two Americans will have the disease. Therefore, as an informed individual, you should be concerned about the high risk of developing cancer even in the absence of family history, significant exposure to carcinogens, or known presence of cancer genes in your body.

Naturally, a discussion of the many causes for the victory and spread of cancer in our population will be appropriate and interesting, but it should be reserved for a lengthy presentation elsewhere (come to our free Tuesday lectures, for example...). The main focus of this article is to provide the reader with valuable diagnostic information of which most patients and health care practitioners are unaware. Specifically, I would like to briefly summarize the benefits of using a laboratory blood test called AMAS (Anti-Malignin Antibody in Serum).

Read full article

A co-worker recently sent me this article posted on Time Magazine's website about tracking free floating cancer cells in people's blood.  Here is an excerpt and a link to Alice Park's article.

"With a disease as complex as cancer, it's easy to forget that sometimes the most effective defense can be the simplest. Despite all the gadgets that modern medicine has to image, diagnose and track a tumor, there is an easier way to go about things. Researchers at the American Society of Clinical Oncology (ASCO) conference in Chicago reported earlier this month that the best way to figure out how a cancer is progressing is to draw a little blood."

Full Story

October is National Breast Cancer Awareness Month.  Race for the Cure is a fund raising walk/race held in many local communities.  Be on the look out for this event in your area.

Oncolab is pleased to announce the completion of its new website. Please explore the new site and provide feedback. Some of the new features include an improved kit order area and a Lab/Doctor search engine to help patients find organizations familiar with the AMAS test.

Suggestions can be emailed to Paul Navitsky